Journal of the National Cancer Institute
Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer.
Erin J Aiello Bowles, Kelli O'Connell, Jenna Bhimani, Grace B Gallagher, Victoria S Blinder, Rachael Burganowski Doud, Isaac J Ergas, Jennifer J Griggs, Narre Heon, Tatjana Kolevska, Yuriy Kotsurovskyy, Candyce H Kroenke, Cecile A Laurent, Raymond Liu, Kanichi G Nakata
Published: 202510.1093/jnci/djaf314
Abstract
BACKGROUND: Older women (>65 years) diagnosed with breast cancer may be at risk for chemotherapy dose reductions. We evaluated associations of age at diagnosis with two measures of chemotherapy dose reductions: first cycle dose proportion (FCDP) <90%…
Preview only. Read the full abstract at the source